100 Eclipsys employees laid off as execs arrive, exit

TriMed Staff | | Health Imaging | Artificial Intelligence
Eclipsys has laid off nearly 100 employees in an effort to put more focus on client support as well as reduce overall operations costs, the company said. Additionally, four executive VPs also have departed.

Meanwhile Jay Deady has been named vice president of customer solutions for the company. Deady is a former McKesson Corp. vice president and general manager.

John Adams, current executive VP, business solutions, has had his job role expanded to encompass outsourcing services and the company's Technology Solutions Center based in Mountain Lakes, N.J.
   
The company expects the $7 million severance costs, and other restructuring costs to have a neutral effect on the company's 2006 earnings, according to a statement.

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.